# An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients.

> **NCT05773976** · NA · TERMINATED · sponsor: **Montefarmaco OTC SpA** · enrollment: 59 (actual)

## Conditions studied

- Opthalomology/Dry Eye

## Interventions

- **DEVICE:** Afomill Refreshing Soothing, Afomill Anti-redness Eye Drops, Iridil

## Key facts

- **NCT ID:** NCT05773976
- **Lead sponsor:** Montefarmaco OTC SpA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-02
- **Primary completion:** 2024-12-24
- **Final completion:** 2024-12-24
- **Target enrollment:** 59 (ACTUAL)
- **Why stopped:** Low enrollment rate
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05773976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05773976, "An Interventional, Confirmative, Post Marketing Clinical Followup (PMCF) Study to Evaluate Performance and Safety of Ophthalmic Solutions Used to Relieve Dry Eyes Like Symptoms in Glaucoma Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05773976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*